Incline Therapeutics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $187M

Incline Therapeutics General Information

Description

Developer of IONSYS, a potential analgesic for adult inpatients requiring opioid pain treatment after surgery. The company develops a compact, disposable, needleless Patient-Controlled Analgesia system for the short-term management of postoperative pain.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 900 Saginaw Drive
  • Suite 200
  • Oakland, CA 94603
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 900 Saginaw Drive
  • Suite 200
  • Oakland, CA 94603
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Incline Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 07-Jan-2013 $187M Completed Product Development
2. Early Stage VC (Series A) 13-Sep-2011 Completed Product Development
1. Merger/Acquisition 22-Jun-2010 Cancelled Product Development
To view Incline Therapeutics’s complete valuation and funding history, request access »

Incline Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Incline Therapeutics’s complete cap table history, request access »

Incline Therapeutics Patents

Incline Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2949709-A1 Switch validation circuit and method Inactive 04-Jun-2014
EP-3151905-A1 Switch validation circuit and method Inactive 04-Jun-2014
EP-3151905-A4 Switch validation circuit and method Inactive 04-Jun-2014
WO-2015187834-A1 Switch validation circuit and method Inactive 04-Jun-2014
ES-2635242-T3 Current control for drug delivery by electrotransport Active 11-Jun-2012 A61N1/325
To view Incline Therapeutics’s complete patent history, request access »

Incline Therapeutics Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
5AM Ventures Venture Capital Minority
Adams Street Partners PE/Buyout Minority
Cadence Pharmaceuticals Corporation Minority
Emergent Medical Partners Venture Capital Minority
Frazier Healthcare Partners PE/Buyout Minority
You’re viewing 5 of 7 investors. Get the full list »

Incline Therapeutics FAQs

  • When was Incline Therapeutics founded?

    Incline Therapeutics was founded in 2009.

  • Where is Incline Therapeutics headquartered?

    Incline Therapeutics is headquartered in Oakland, CA.

  • What industry is Incline Therapeutics in?

    Incline Therapeutics’s primary industry is Drug Discovery.

  • Is Incline Therapeutics a private or public company?

    Incline Therapeutics is a Private company.

  • What is the current valuation of Incline Therapeutics?

    The current valuation of Incline Therapeutics is .

  • What is Incline Therapeutics’s current revenue?

    The current revenue for Incline Therapeutics is .

  • How much funding has Incline Therapeutics raised over time?

    Incline Therapeutics has raised $43M.

  • Who are Incline Therapeutics’s investors?

    5AM Ventures, Adams Street Partners, Cadence Pharmaceuticals, Emergent Medical Partners, and Frazier Healthcare Partners are 5 of 7 investors who have invested in Incline Therapeutics.

  • When was Incline Therapeutics acquired?

    Incline Therapeutics was acquired on 07-Jan-2013.

  • Who acquired Incline Therapeutics?

    Incline Therapeutics was acquired by The Medicines Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process